Knowledge - IMSDA

India’s Generic Medicine Supply Chain: NITI Aayog Warns of Critical Chinese API Dependence

Post published:June 24, 2026
Post category:Knowledge

India’s pharmaceutical industry supplies roughly 40 percent of the United States’ generic medicines and approximately 20 percent of global demand. Yet behind this impressive export footprint lies a structural vulnerability…

India Pharma Knowledge Roundup June 2026: Women’s Health, Semaglutide Boom and Quality Reform

Post published:June 22, 2026
Post category:Knowledge

June 2026 marks a pivotal moment for India's generic pharmaceutical industry. From landmark shifts toward women's health therapeutics to explosive growth in the generic GLP-1 market and sweeping drug-quality reforms,…

Understanding Bioequivalence: Why Indian Generic Medicines Work as Well as Branded Drugs

Post published:June 22, 2026
Post category:Knowledge

One of the most common questions international buyers ask about Indian generic medicines is: "Are they really as effective as the original branded drug?" The answer lies in a rigorous…

How to Verify the Quality of Indian Generic Medicine Manufacturers: A Buyer’s Guide

Post published:June 20, 2026
Post category:Knowledge

India is the world's largest supplier of generic medicines, exporting over US$25 billion worth of pharmaceuticals annually to more than 200 countries. But with volume comes risk — not all…